Here's What's New In The World Of Investing...

The Daily Dividend 12/12/25

In partnership with

Good morning and happy Friday!

It may be the end of the trading week, but there’s still plenty of exciting news rolling in. We’ve got three companies that are all raising their dividends, including what some consider “the best performing stock of the last 30 years.”

But first, let’s start with a niche consumer staple that’s hiking its payout by an astonishing 13.9%…

Oil-Dri Corporation of America ($ODC) Raises Dividend By 13.9%

Oil-Dri Corporation of America produces “specialty sorbent products” used to absorb liquid spills.

The company’s specialty absorbents are used in cat litter, industrial spill cleanup, and agricultural products. You may recognize some of the firm’s brands such as Cat's Pride and Ultra Pet.

Oil-Dri was founded in 1941 and has paid dividends every year since 1974. And, earlier this week, the company announced a 13.9% dividend raise.

Oil-Dri Corporation of America will now pay a $0.205/share quarterly dividend.

  • Ex-dividend date: 2/20/26

  • Payout date: 3/6/26

  • Forward starting dividend yield: 1.72%

Balchem Corporation ($BCPC) Raises Dividend By 10.3%

Often considered “the best performing stock of the last 30 years,” Balchem Corporation gained more than 107,000% between 1985 and 2016. And while this company still posts solid returns, its growth has slowed in recent years.

Balchem Corporation makes specialty ingredients and additives that are used in foods, drinks, supplements, and pharmaceutical products.

Using the chemical process of “chelation” to increase nutrient absorption in animal feed may not sound exciting. But, services like this are allow Balchem to consistently grow its dividend at a rate that outpaces inflation.

The firm has a five year compound annual dividend growth rate of 10.84%. And this week, Balchem announced a 10.3% increase to its yearly dividend.

Balchem Corporation will now pay a $0.96/share annual dividend.

  • Ex-dividend date: 12/23/25

  • Payout date: 1/20/26

  • Forward starting dividend yield: 0.64%

Bristol-Myers Squibb Company ($BMY) Raises Dividend By 1.6%

Bristol-Myers Squibb Company has faced a rough decade. The stock has delivered a measly total return of just 4.46% since 2015.

Still, there is a silver lining.

Bristol-Myers Squibb is a global pharmaceutical company that develops prescription medicines used to combat serious diseases. The company produces oncology treatments, medications that help resolve blood disorders, and autoimmune therapies.

Additionally, Bristol-Myers Squibb has paid dividends every year for 94 years. And, the company has raised its dividend for 17 consecutive years.

Recently, Bristol-Myers Squibb announced a 1.6% dividend increase.

Bristol-Myers Squibb Company will now pay a $0.63/share quarterly dividend.

  • Ex-dividend date: 1/2/26

  • Payout date: 2/2/26

  • Forward starting dividend yield: 4.92%

Homeowners: Don’t miss winter insurance savings

EverQuote is designed to make your seasonal insurance refresh effortless.

Fast Process: Skip repetitive forms and get matched in minutes.

More Ways to Save: Compare rates from both national and local carriers.

Winter-Ready Coverage: Enter the holidays with clarity and confidence.

And for homeowners, the benefits can go even further. Many qualify for lower auto insurance rates, and reviewing your options now can lead to real savings before winter weather peaks. With EverQuote, checking those potential savings takes only moments.

Whether you’re hauling gifts, driving through snow, or gearing up for the new year, now is the perfect time to ensure your coverage keeps you protected—and your holiday budget comfortable.

Thank you for reading and stay tuned for an exciting new special report coming to your inbox tomorrow. Plus, a new “Market Bites” on Sunday, exclusive to email subscribers.

P.S. Enjoying the newsletter? Forward it to a friend who loves dividends.

Disclaimer: This article is for entertainment purposes only. It is not financial advice, always do your own research.